Published: Nov. 14, 2023 at 5:28 p.m. ET
Shares of Corbus Pharmaceuticals Holdings Inc. CRBP rocketed 22.47% to $3.87 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 2.37% to 14,094.38 and the Dow Jones Industrial Average DJIA rising 1.43% to 34,827.70.
Corbus Pharmaceuticals Holdings Inc. closed $9.30 below its 52-week high ($13.17), which the company reached on April 19th.
The…
Shares of Corbus Pharmaceuticals Holdings Inc.
CRBP
rocketed 22.47% to $3.87 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index
COMP
rising 2.37% to 14,094.38 and the Dow Jones Industrial Average
DJIA
rising 1.43% to 34,827.70.
Corbus Pharmaceuticals Holdings Inc. closed $9.30 below its 52-week high ($13.17), which the company reached on April 19th.
The stock outperformed some of its competitors Tuesday, as Vanda Pharmaceuticals Inc.
VNDA
rose 4.11% to $3.55, Fortress Biotech Inc.
FBIO
fell 1.49% to $1.32, and Viking Therapeutics Inc.
VKTX
rose 12.49% to $11.17.
Trading volume (17,928) eclipsed its 50-day average volume of 10,942.
Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Read More: Corbus Pharmaceuticals Holdings Inc. stock outperforms market on strong trading